Friday, 13 December 2019

Pharma/BioPharma News

  • Panacea Biotec launches anti-diabetes drug ViLACT

    Pharma/BioPharma |  News | 0 Comment | 11 Dec, 2019

    Panacea Biotec is pleased to announce launch of brand ViLACT in India. ViLACT is used in the treatment of Uncontrolled Type 2 Diabetes Mellitus patients with HbA1c >6.5%.   VilACT...Read more

  • FDA approves Amgen's biosimilar AVSOLA

    Pharma/BioPharma |  News | 0 Comment | 09 Dec, 2019

    Amgen has announced that the U.S. Food and Drug Administration (FDA) has approved AVSOLA™ (infliximab-axxq) for all approved indications of the reference product, Remic...Read more

  • HEC Pharm, Biocon, Sun Pharma get FDA approval for MS drug

    Pharma/BioPharma |  News | 0 Comment | 06 Dec, 2019

    The U.S. Food and Drug Administration has approved three applications for first generics of Gilenya (fingolimod) capsules for the treatment of relapsing forms of multiple sclerosis (MS) in ...Read more

  • Mankind develops drug for pregnancy related complications

    Pharma/BioPharma |  News | 0 Comment | 06 Dec, 2019

    Mankind Pharma, a Rs 5,600 crore pharmaceutical company, has launched a Dydrogesterone-containing drug, for treatment of pregnancy-related complications. Mankind Pharma becomes the first In...Read more

  • Strides gets USFDA tentative nod for pain relieving drug

    Pharma/BioPharma |  News | 0 Comment | 05 Dec, 2019

    Strides Pharma Science Limited (Strides) has announced that its step‐down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received tentative approval for Diclo...Read more

  • Eris buys Zomelis from Novartis AG for $13M

    Pharma/BioPharma |  News | 0 Comment | 05 Dec, 2019

    Gujarat based Eris Lifesciences has announced the acquisition of the trademark Zomelis (for Vildagliptin based formulations) and its associated trademarks from Novartis AG, Switzerland...Read more

  • Biocon, Mylan launch Ogivri in the US

    Pharma/BioPharma |  News | 0 Comment | 03 Dec, 2019

    Biocon Ltd. and Mylan N.V. have announced the U.S. launch of Ogivri™ (trastuzumab-dkst), a biosimilar to Herceptin® (trastuzumab). Ogivri i...Read more

  • CAS launches Formulus in India

    Pharma/BioPharma |  News | 0 Comment | 03 Dec, 2019

    CAS, a division of the American Chemical Society that specializes in scientific information solutions, has now launched Formulus® in India, the collection of formulations sour...Read more

  • IMCD opens 3 Pharma Technical Centres in Asia Pacific

    Pharma/BioPharma |  News | 0 Comment | 28 Nov, 2019

    Netherlands based IMCD N.V., a leading distributor of speciality chemicals and food ingredients, has announces the expansion of its global network of Pharmaceutical Technical Centres with t...Read more

  • 13th CPhI & P-MEC India Expo transforms global Pharma space

    Pharma/BioPharma |  News | 0 Comment | 26 Nov, 2019

    The 13th edition of South Asia’s biggest Pharma event, CPhI & P-MEC India expo, a three-day exhibition is being held from November 26th – 28th,...Read more

  • Alembic Pharma set to treat benign prostatic hyperplasia

    Pharma/BioPharma |  News | 0 Comment | 26 Nov, 2019

    Alembic Pharmaceuticals Limited has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Silodosin Capsules, 4 mg and 8...Read more

  • FDA approves novel treatment for sickle cell disease abnormalities

    Pharma/BioPharma |  News | 0 Comment | 26 Nov, 2019

    The U.S. Food and Drug Administration granted accelerated approval to Oxbryta (voxelotor) for the treatment of sickle cell disease (SCD) in adults and pediatric patients 12 years of age and...Read more

  • India to grow strongly in 2020 as CPhI & P-MEC India opens

    Pharma/BioPharma |  News | 0 Comment | 25 Nov, 2019

    CPhI & P-MEC India – organised by Informa Markets – is set to open its doors from 26-29 November, at Greater Noida, to more than 43,000 attendees from 120 countries and...Read more

  • Roche launches small cell lung cancer drug in India

    Pharma/BioPharma |  News | 0 Comment | 22 Nov, 2019

    Atezolizumab is the first cancer immunotherapy to receive an approval in India for the first line treatment of ES-SCLC when given in combination with chemotherapy. Clinical study has shown ...Read more

  • Lupin launches generic KCl for Oral Solution USP, 20 mEq

    Pharma/BioPharma |  News | 0 Comment | 20 Nov, 2019

    Lupin has announced the launch of Potassium Chloride (KCl) for Oral Solution USP, 20 mEq, having received an approval from the USFDA earlier. Lupin’s Potassium Chloride for Oral Solu...Read more

  • South Asia’s largest Pharma event to kick start in India

    Pharma/BioPharma |  News | 0 Comment | 19 Nov, 2019

    Informa Markets in India (Formerly UBM India), a leading B2B exhibition organizer, gears up to kick start South Asia’s largest Pharma event, CPhI & P-MEC India Expo. Driving the g...Read more

  • Advent to acquire majority stake in Bharat Serums

    Pharma/BioPharma |  News | 0 Comment | 20 Nov, 2019

    Advent International (“Advent”), one of the largest and most experienced global private equity investors has signed a definitive agreement to acquire a majority interest in Bhar...Read more

  • Chiron Behring re-launches Rabies Vaccine as Chirorab

    Pharma/BioPharma |  News | 0 Comment | 14 Nov, 2019

    Chiron Behring Vaccines has announced the re-launch its purified chick embryo cell (PCEC) vaccine manufactured at its WHO pre-qualified facility in Ankleshwar, Gujarat as Chirorab®...Read more